Dublin-based device maker Medtronic received US Food and Drug Administration (FDA) approval on September 28 to sell the first hybrid closed-loop automated insulin delivery device, the MiniMed 670G, ...

International Diabetes Federation estimates about 415 million people worldwide suffer from diabetes, a number that is expected to increase. Of these, 5% - 10% have Type I diabetes. According to a ...

Medtronic plcMDT announced that the FDA has approved a new arm indication for the Guardian Sensor 3 continuous glucose monitor (CGM) used with the MiniMed 670G insulin pump. Notably, the Guardian ...

DUBLIN - June 24, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced real-world clinical outcomes for 32,178 users of the MiniMed(TM) 670G system. Data on more than 2 ...

Aggregated real-world outcome data collected from thousands of Medtronic MiniMed 670G users indicate that patients on the system spend an average 71% of their time within an optimal glycemic range.